[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"pelvic-pain-syndrome\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:pelvic-pain-syndrome":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,49,78,108,133,162,182,210],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":32,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100608750","the-good-pain-consultation-in-endometriosis-100608750",false,"NCT07205614","The Good Pain Consultation in Endometriosis.","Inclusion Criteria:\n\n* biological women\n\nExclusion Criteria:\n\n* not speaking norwegian","FEMALE","16 Years","50 Years",{"count":19,"type":20},110,"ESTIMATED","INTERVENTIONAL",[23],"NA","This PhD project investigates the effect of \"the good pain consultation\" and early integration of biopsychosocial pain education with current standard management of endometriosis. Our goal is to facilitate self-management of pain and improve health-related quality of life (HRQOL) using limited resources.\n\nOur research question is: Does a good pain consultation improve pain self-efficacy and HRQOL, compared to usual care at 3 months and 1 year.?\n\nResearchers will compare a good pain consultation to a control group that will receive usual care.\n\nParticipants will:\n\nAttend a consultation and biopsychososial pain education plus usual care or usual care alone.\n\nThey will answer questions in an internet-based questionnaires three times point during the study.",[26,27,28,29,30,31],"Pelvic Pain Syndrome","Endometriosis","Dysmenorrhea","Adenomyosis","Period Pain","Menstrual Pain",[33,34,35],"pain education","biopsychosocial","randomised controlled trial","RECRUITING","2026-04-22",{"date":39,"type":40},"2026-04-28","ACTUAL",{"date":42,"type":40},"2025-11-01",{"date":44,"type":20},"2028-06-01",{"name":46,"class":47},"Sorlandet Hospital HF","OTHER_GOV",1,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":11,"sex":15,"minAge":57,"maxAge":58,"enrollmentInfo":59,"targetDuration":4,"studyType":61,"phases":4,"briefSummary":62,"conditions":63,"keywords":4,"overallStatus":67,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":4},"100632699","intraoperative-sono-assessment-in-deep-endometriosis-100632699","NCT07517081","Intraoperative Sono-assessment In Deep Endometriosis","Intraoperative Ultrasound in Rectal Shaving for Deep Infiltrating Endometriosis: Evaluation of Residual Disease, Bowel Wall Thickness, and Clinical Outcomes","INSIDE","Inclusion Criteria:\n\n* Female patients aged 20-60 years\n* Rectal or sigmoid nodule with muscularis propria infiltration ≥1 mm and \\\u003C20 mm (assessed by expert transvaginal ultrasound)\n* Indication for surgery agreed upon with the patient\n* Written informed consent\n\nExclusion Criteria:\n\n* Previous major bowel surgery or primary indication for bowel resection\n* Inflammatory bowel disease, malignancy, or severe pelvic pathology\n* Inability to complete study questionnaires","20 Years","60 Years",{"count":60,"type":20},57,"OBSERVATIONAL","Deep infiltrating endometriosis (DIE) involving the bowel, particularly the rectosigmoid region, is associated with significant gastrointestinal symptoms and impaired quality of life. Rectal shaving is a conservative surgical technique aimed at removing endometriotic lesions while preserving bowel integrity; however, it may result in residual disease or excessive thinning of the bowel wall, potentially leading to recurrence or complications.\n\nIntraoperative ultrasound (IOUS) allows real-time assessment of residual nodule thickness and bowel wall thickness after shaving. This prospective observational study aims to evaluate the relationship between intraoperative ultrasound measurements and postoperative clinical outcomes, including gastrointestinal symptoms and quality of life.\n\nThe study also seeks to identify ultrasound cut-off values that may guide intraoperative surgical decision-making and optimize the balance between radicality and safety.",[27,64,26,65,66],"Endometriosis-related Pain","Endometriosis, Rectum","Endometriosis of Colon","NOT_YET_RECRUITING","2026-04-01",{"date":70,"type":40},"2026-04-08",{"date":72,"type":20},"2026-04-07",{"date":74,"type":20},"2028-07-07",{"name":76,"class":77},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","OTHER",{"id":79,"slug":80,"hasResults":11,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":84,"eligibilityCriteria":85,"healthyVolunteers":11,"sex":15,"minAge":86,"maxAge":4,"enrollmentInfo":87,"targetDuration":4,"studyType":21,"phases":89,"briefSummary":90,"conditions":91,"keywords":92,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":48},"100465745","fotonasmooth-erbiumyag-laser-for-the-treatment-of-urethral-pain-syndrome-in-women-100465745","NCT05344716","FotonaSmooth Erbium:YAG Laser for the Treatment of Urethral Pain Syndrome in Women","Monocentric, Prospective Pilot Study to Test the Efficacy and Safety of the FotonaSmooth Erbium:YAG Laser for the Treatment of Urethral Pain Syndrome in Women","UPS-IUL","Inclusion Criteria:\n\n* Adult female, 18 years of age or older\n* Urethral pressure pain upon palpation, VAS Score ≥ 2\n* Intermittent or chronic pain in the urethra and\u002For the small pelvis (independent of micturition) for at least 6 months\n* No significant improvement of UPS from at least one previous conservative treatment (pessary, antibiotics, local oestrogens etc.)\n* Signed informed consent\n\nExclusion Criteria:\n\n* Pregnancy\n* Treatment with Isotretinoin (Acne, Rosacea) within last 6 months\n* Acute urinary tract infection or other acute infection of the bladder, vagina, vulva or urinary tract detected by routine urine analysis\n* Positive urethral swab for Ureaplasma, Mycoplasma or Chlamydia ≤ 6 weeks. Exception: Patients with chronic and persistent fastidious bacteria can be included six weeks after two unsuccessful treatments with antibiotics. Antibiotics therapy must also include sexual partners.\n* Pre-existing bladder or urethra pathology\n* Interstitial Cystitis\n* Endometriosis\n* Diagnosis of collagen disorders, e.g. benign joint hypermobility \u002F Elhers-Danlos \u002F Marfans etc.\n* Vesicovaginal fistula\n* Unwillingness or inability to complete follow-up schedule\n* Unwillingness or inability to give informed consent\n* Unwillingness or inability to complete questionnaires","18 Years",{"count":88,"type":20},30,[23],"Urethral pain syndrome (UPS) is defined by the occurrence of persistent or recurrent episodic urethral pain in the absence of proven infection or other obvious pathology. The objective of this study is to determine the effect of an intraurethral and vaginal laser therapy for the treatment of UPS. The hypothesis is that a significant reduction of urethral pressure pain can be achieved.",[26],[93,94,95,96,97,98],"urethra","pain","laser","intraurethral","erbium","fotona","2026-03-19",{"date":101,"type":40},"2026-03-23",{"date":103,"type":40},"2022-09-01",{"date":105,"type":20},"2027-12",{"name":107,"class":77},"Prof. Dr. Volker Viereck",{"id":109,"slug":110,"hasResults":11,"nctId":111,"briefTitle":112,"officialTitle":112,"acronym":4,"eligibilityCriteria":113,"healthyVolunteers":11,"sex":15,"minAge":86,"maxAge":4,"enrollmentInfo":114,"targetDuration":4,"studyType":21,"phases":116,"briefSummary":117,"conditions":118,"keywords":120,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":124,"lastUpdatePostDateStruct":125,"startDateStruct":127,"completionDateStruct":129,"leadSponsor":131,"locationsCount":48},"100629297","study-on-the-outcomes-of-patients-treated-in-gynecological-emergency-departments-for-pelvic-endometriosis-or-suspected-pelvic-endometriosis-100629297","NCT07472842","Study on the Outcomes of Patients Treated in Gynecological Emergency Departments for Pelvic Endometriosis or Suspected Pelvic Endometriosis","Inclusion Criteria :\n\n* Adult patient (aged 18 or over)\n* Patient consulting the gynecological emergency department at Créteil Hospital for\n* Known endometriosis or\n* Symptoms suggestive of endometriosis: dysmenorrhea, pelvic pain, cyclic dysuria, dyspareunia, cyclic dyschezia, infertility, rectal bleeding, chest pain, catamenial hematuria\n* Patient who speaks French and is able to understand the information sheet\n\nExclusion Criteria:\n\n* Minor or menopausal patient\n* Pregnant and breastfeeding patient\n* Other reason for consultation\n* Patient refusal\n* Patient not affiliated with a social security system\n* Patient cannot be contacted for the 3-months questionnaire",{"count":115,"type":20},200,[23],"Adult patients consulting the gynecological emergency department of CHI Créteil during the inclusion period for endometriosis or symptoms suggestive of endometriosis",[27,26,119],"Chronic Gynaecological Disease",[121,122,123],"infertility","dysmenorrhea","pelvic pain","2026-03-12",{"date":126,"type":40},"2026-03-16",{"date":128,"type":40},"2025-10-16",{"date":130,"type":20},"2026-07-15",{"name":132,"class":77},"Centre Hospitalier Intercommunal Creteil",{"id":134,"slug":135,"hasResults":11,"nctId":136,"briefTitle":137,"officialTitle":138,"acronym":139,"eligibilityCriteria":140,"healthyVolunteers":141,"sex":15,"minAge":86,"maxAge":142,"enrollmentInfo":143,"targetDuration":4,"studyType":21,"phases":145,"briefSummary":146,"conditions":147,"keywords":4,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":152,"lastUpdatePostDateStruct":153,"startDateStruct":155,"completionDateStruct":157,"leadSponsor":159,"locationsCount":161},"100528998","trial-of-ovarian-vein-and-pelvic-vein-embolization-in-women-with-chronic-pelvic-pain-and-pelvic-varices-100528998","NCT06168058","Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices","Randomized Controlled, Single-Blinded, Parallel-Group Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices (EMBOLIZE) Trial","EMBOLIZE","Inclusion Criteria:\n\n1. Presence of venous origin chronic pelvic pain for greater than 6 months (VAS ≥7 as determined by 4 consecutive weeks of baseline self-assessments) despite non-vascular therapy as delineated by the following criteria:\n\n   * Pain exacerbated by walking, standing or lifting\n   * Symptoms are at least partially alleviated by lying down\n   * Prolonged post-coital ache\n   * Absence of non-venous origin CPP as determined by Gynecology examination\n2. Symptoms-Varices-Pathophysiology Classification18 including of one of the following:\n\n   •S2V2PBGV,R,NT, S2V2PRGV,R,NT , S2V2PLGV,R,NT, with or without S2V2 PBIIV,R,NT, S2V2 PLIIV,R,NT, S2V2 PRIIV,R,NT\n3. CT, TAUS and diagnostic venography (if needed) imaging review for pelvic venous imaging factors\n\n   * Left or right ovarian vein diameter greater than or equal to 6 mm as documented by TAUS or CT\n   * Presence of intrabdominal\u002Fpelvic varices as documented by TAUS or CT (≥1 veins, \\>5 mm diameter)\n   * Presence of venous reflux in ovarian and\u002For internal iliac veins without evidence of hemodynamically significant stenosis\n\nExclusion Criteria:\n\n* Female \\\u003C18 years of age\n* Pregnancy (positive pregnancy test)\n* Female subject who plans to become pregnant during study period\n* Female subject who is actively breastfeeding\n* Patient who is post-menopausal or anovulatory with hormone suppression\n* History of prior hysterectomy\n* Prior ovarian vein embolization or ovarian vein ligation\n* Inability to tolerate endovascular procedure due to acute illness or general health\n* Planned simultaneous treatment with nerve blocks during the duration of the study\n* Laparoscopy or planned surgical intervention during the duration of the study\n* Known allergy to sclerosant, coil, stent or catheter components including nickel allergy\n* Any iliac vein stenosis determined identified by the investigator on pelvic DUS, CT venogram, and\u002For Catheter Venography and deemed significant for exclusion by study patient review committee.\n* Any renal vein stenosis with resultant renal hilar varices\u002Fcollaterals and lumbar collaterals identified by the investigator on pelvic DUS, CT venogram, and\u002For Diagnostic Venography and deemed significant for exclusion by study patient review committee.\n* Presence of isolated extra-pelvic vulvar and\u002For lower extremity varices without intrabdominal pelvic varices. Primary S3 categorization study exclusion.\n* Serious medical conditions that might preclude full participation in the study to the desired endpoint (e.g., uncontrolled diabetes, malignancy, COPD, MI, CHF, etc.)\n* Severe allergy to iodinated or gadolinium-based contrast refractory to steroid premedication\n* Severe renal impairment (on chronic dialysis or estimated GFR \\\u003C30 mL\u002Fmin)\n* Hemoglobin \\\u003C8.0 g\u002FdL, uncorrectable INR \\>3.0 or platelet count \\\u003C75,000\u002Fmicroliter\n* Inability to provide informed consent or to comply with study assessments\n* Post thrombotic IVC, iliac or ovarian vein changes",true,"75 Years",{"count":144,"type":20},40,[23],"The purpose of this study is to see if a randomized controlled trial of ovarian vein and pelvic vein embolization versus venography alone could determine outcomes for women with chronic pelvic pain and pelvic varicose veins.\n\nThe data gathered will assist in addressing changes in quality of life in patients who have ovarian\u002Fpelvic vein embolization versus no embolization.",[148,149,150,151,26],"Chronic Pelvic Pain Syndrome","Pelvic Pain","Pelvic Varices","Pelvic Congestive Syndrome","2026-03-11",{"date":154,"type":40},"2026-03-13",{"date":156,"type":40},"2025-08-07",{"date":158,"type":20},"2027-06",{"name":160,"class":77},"Weill Medical College of Cornell University",3,{"id":163,"slug":164,"hasResults":11,"nctId":165,"briefTitle":166,"officialTitle":167,"acronym":168,"eligibilityCriteria":169,"healthyVolunteers":11,"sex":15,"minAge":86,"maxAge":17,"enrollmentInfo":170,"targetDuration":4,"studyType":61,"phases":4,"briefSummary":172,"conditions":173,"keywords":4,"overallStatus":67,"whyStopped":4,"lastUpdateSubmitDate":174,"lastUpdatePostDateStruct":175,"startDateStruct":177,"completionDateStruct":179,"leadSponsor":181,"locationsCount":4},"100626777","relugolix-for-endometriosis-associated-pain-100626777","NCT07440043","Relugolix for Endometriosis Associated Pain","An Ambispective, Single-center Observational Study Evaluating the Effectiveness of Relugolix Combination Therapy in Reducing Endometriosis-associated Pain Over 24 Weeks in a Real-world Clinical Setting","RELAX","Inclusion Criteria:\n\n* Female aged between 18 and 50 years\n* Endometriosis confirmed laparoscopically or radiologically (via ultrasound or MRI)\n* Receiving treatment with Relugolix CT according to clinical practice for at least one month\n* Pain score ≥40 on the VAS scale\n* Regular menstrual cycles, (i.e., not in a menopausal or perimenopausal state)\n* Signed informed consent\n\nExclusion Criteria:\n\n\\- Menopausal status (natural or surgical)",{"count":171,"type":20},33,"Endometriosis is a chronic, estrogen-dependent condition frequently associated with pelvic pain and reduced quality of life. Relugolix combination therapy (CT), an oral GnRH receptor antagonist-based treatment, has demonstrated efficacy in randomized clinical trials, but real-world data remain limited.\n\nThe RELAX study is a single-center, ambispective observational study evaluating the effectiveness of relugolix CT in reducing endometriosis-associated pain over 24 weeks in routine clinical practice. The primary endpoint is the change from baseline in pelvic pain measured by the Visual Analog Scale (VAS). Secondary outcomes include changes in pain-related symptoms, ultrasonographic findings, patient satisfaction, and safety.",[27,64,26],"2026-02-23",{"date":176,"type":40},"2026-02-27",{"date":178,"type":20},"2026-02-25",{"date":180,"type":20},"2027-02-28",{"name":76,"class":77},{"id":183,"slug":184,"hasResults":11,"nctId":185,"briefTitle":186,"officialTitle":187,"acronym":4,"eligibilityCriteria":188,"healthyVolunteers":141,"sex":189,"minAge":57,"maxAge":190,"enrollmentInfo":191,"targetDuration":4,"studyType":61,"phases":4,"briefSummary":193,"conditions":194,"keywords":199,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":201,"lastUpdatePostDateStruct":202,"startDateStruct":204,"completionDateStruct":206,"leadSponsor":208,"locationsCount":48},"100523978","chronic-pelvic-pain-in-females-and-males-100523978","NCT06102733","Chronic Pelvic Pain in Females and Males","Chronic Pelvic Pain Management in Female and Male Adult Patients","Inclusion Criteria:\n\n* Patients with chronic pelvic pain\n* Patients with sacroiliac pain\n* Patients with inguinal pain\n* Patients with coccygeal pain\n* Patients with piriformis pain\n\nExclusion Criteria:\n\n* Patients with spinal pain\n* Patients who had spine surgery","ALL","99 Years",{"count":192,"type":20},1000,"Pelvic pain is under-reported in healthy adults. Many patients with pelvic pain under-estimate the problem. Chronic pelvic pain can be managed properly, if diagnosed promptly.\n\nThis is a quantitative analysis of prospective clinical data. It evaluates the management of pelvic pain in a cohort population, and analyzes the treatment outcome.",[26,195,196,197,198],"Sacroiliac Disorder","Piriformis Syndrome","Sacrococcygeal Disorder","Inguinal Hernia",[200],"Pelvic pain","2025-01-23",{"date":203,"type":40},"2025-01-27",{"date":205,"type":40},"2018-01-02",{"date":207,"type":20},"2025-12-31",{"name":209,"class":77},"Salem Anaesthesia Pain Clinic",{"id":211,"slug":212,"hasResults":11,"nctId":213,"briefTitle":214,"officialTitle":215,"acronym":4,"eligibilityCriteria":216,"healthyVolunteers":11,"sex":15,"minAge":86,"maxAge":217,"enrollmentInfo":218,"targetDuration":4,"studyType":61,"phases":4,"briefSummary":220,"conditions":221,"keywords":223,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":230,"lastUpdatePostDateStruct":231,"startDateStruct":233,"completionDateStruct":235,"leadSponsor":236,"locationsCount":48},"100525663","study-of-venous-outflow-from-the-lower-limbs-in-patients-with-pelvic-varicosities-100525663","NCT06124664","Study of Venous Outflow From the Lower Limbs in Patients With Pelvic Varicosities","Study of Venous Outflow From the Lower Limbs in Patients With Pelvic Varicosities as a New Strategy for Compression Treatment of Pelvic Varicose Veins and Varicose Veins of the Lower Limb","Inclusion Criteria:\n\n* Patient age from 18 to 40 years;\n* Presence of pelvic varicose veins according to DUS data;\n* Reflux in the pelvic veins for more than 1 second before this DUS;\n* Reflux in the superficial veins of the lower limbs.\n\nExclusion Criteria:\n\n* Menopause;\n* Pregnancy;\n* Postthrombotic disease;\n* Suspicion of May-Turner syndrome;\n* Ultrasound signs of nutcracker syndrome","40 Years",{"count":219,"type":20},90,"Compression therapy is basic treatment for chronic venous disease (CVD) of the lower limbs. Numerous studies have demonstrated the efficacy and safety of compression therapy in relieving symptoms such as pain, venous edema, leg heaviness and fatigue, as well as accelerating the healing of venous ulcers. It has been established that сompression therapy is indicated for patients with both minimally expressed manifestations of CVD and severe forms of the disease. At the same only one study has been conducted to assess the correction of venous outflow from the lower limbs and pelvis in patients with pelvic varicose vein (PVV) and pelvic congestion syndrome (PCS). However, the incidence of this pathology ranges from 15 to 30% in the female population. The cost to the healthcare system of treating these patients in the United States exceeds $2 billion. To date, the options and indications for compression therapy in patients with concomitant PVV and CVD have not been defined. The rational use of compression in this cohort of patients may contribute to the improvement of effective conservative treatment. In addition, inappropriate prescription of compression to patients with pelvic venous disease (which can be observed in real clinical practice) may discredit this simple, effective and safe therapeutic method. In addition, the research devoted to the problem of compression treatment of PVV will contribute to the development of new special compression products aimed at accelerating venous outflow from the pelvic organs. It can be assumed that this will serve as a stimulus for obtaining new data on the therapeutic effects of compression and create conditions for the creation of new technological directions in the production of compression knitwear.",[150,222,26,151],"Varicose Veins of Lower Limb",[224,225,226,227,228,229],"pelvic varicose vein","venous outflow","chronic venous disease","compression treatment","duplex ultrasound","single-photon emission computed tomography","2024-12-25",{"date":232,"type":40},"2024-12-27",{"date":234,"type":40},"2023-05-12",{"date":230,"type":20},{"name":237,"class":77},"Pirogov Russian National Research Medical University"]